Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunology of tuberculosis

N E Dunlap1, D E Briles

  • 1Division of Pulmonary and Critical Care Medicine, University of Alabama at Birmingham.

The Medical Clinics of North America
|November 1, 1993
PubMed
Summary

Tuberculosis (TB) is a chronic infection caused by Mycobacterium tuberculosis. Effective control relies on cellular immunity, though it can paradoxically harm the host, while humoral immunity offers little protection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Avasopasem manganese (GC4419) protects against cisplatin-induced chronic kidney disease: An exploratory analysis of renal metrics from a randomized phase 2b clinical trial in head and neck cancer patients.

Redox biology·2023
Same author

Pneumococcal Vaccines.

Microbiology spectrum·2019
Same author

Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques.

Mucosal immunology·2015
Same author

Asthma and antibodies to pneumococcal virulence proteins.

Infection·2013
Same author

Prospects for use of interleukin-12 as a mucosal adjuvant for vaccination of humans to protect against respiratory pneumococcal infection.

Vaccine·2008
Same author

Fusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition.

Infection and immunity·2007

Area of Science:

  • Immunology
  • Infectious Diseases
  • Microbiology

Background:

  • Tuberculosis (TB) is a chronic, necrotizing infectious disease caused by Mycobacterium tuberculosis.
  • Disease presentation results from the interplay between host immune response and bacterial virulence factors.

Purpose of the Study:

  • To elucidate the roles of cellular and humoral immunity in tuberculosis pathogenesis.
  • To understand the mechanisms underlying host susceptibility and disease dissemination.

Main Methods:

  • Review of existing literature on host-pathogen interactions in TB.
  • Analysis of the immunological mechanisms involved in controlling Mycobacterium tuberculosis infection.
  • Examination of the impact of host immune status on TB clinical manifestations.

Main Results:

  • Cellular immunity is crucial for controlling Mycobacterium tuberculosis infection.
  • Cytokine release during cellular immune responses can lead to host tissue damage.
  • Humoral immunity contributes minimally to protection against TB.
  • Impaired cellular immunity significantly increases susceptibility to TB and disseminated disease.

Conclusions:

  • Cellular immunity plays a dual role in TB, providing protection but also causing immunopathology.
  • Deficiencies in cellular immunity predispose individuals to severe and disseminated forms of tuberculosis.
  • Understanding these immune dynamics is key for developing effective TB therapies.

Related Experiment Videos